https://inpracticeoncology.com/news/ivonescimab-plus-chemotherapy-extends-os-in-advanced-squamous-nsclc/ 2026-06-18T13:18:36+00:00 https://inpracticeoncology.com/news/introducing-in-practice/ 2026-06-18T13:28:16+00:00 https://inpracticeoncology.com/news/d-vrd-multiple-myeloma-fda-approval/ 2026-06-18T13:48:05+00:00 https://inpracticeoncology.com/news/venetoclax-dosing-azole-antifungals/ 2026-06-18T13:49:34+00:00 https://inpracticeoncology.com/news/north-american-enrollment-in-clinical-trials/ 2026-06-18T14:04:14+00:00 https://inpracticeoncology.com/news/patient-navigators-clinical-trials-cancer/ 2026-06-18T14:05:33+00:00 https://inpracticeoncology.com/news/virtual-research-nurse-community-oncology-trials/ 2026-06-18T14:06:21+00:00 https://inpracticeoncology.com/news/fda-aems-adverse-event-monitoring-system/ 2026-06-18T14:09:10+00:00 https://inpracticeoncology.com/news/pembrolizumab-chemo-combo-enhances-advanced-endometrial-cancer-care/ 2026-06-18T14:11:40+00:00 https://inpracticeoncology.com/news/adjuvant-selpercatinib-improves-outcomes-in-ret-positive-early-stage-nsclc/ 2026-06-18T14:19:31+00:00 https://inpracticeoncology.com/news/improving-disease-control-in-dedifferentiated-liposarcoma-with-cdk4-inhibition/ 2026-06-18T14:20:00+00:00 https://inpracticeoncology.com/news/proteus-supports-perioperative-apalutamide-plus-adt-for-high-risk-prostate-cancer/ 2026-06-18T14:20:23+00:00 https://inpracticeoncology.com/news/social-risk-factor-screening-cancer-survivorship/ 2026-06-18T14:55:52+00:00 https://inpracticeoncology.com/wp-content/uploads/2026/06/INP_26_014-Integrating-Social-Risk-Factor-Screening-in-Cancer-Survivorship-Care-Insights-From-a-Qualitative-Study-1024x574-1.png https://inpracticeoncology.com/news/daraxonrasib-improves-survival-outcomes-in-previously-treated-metastatic-pdac/ 2026-06-19T17:47:53+00:00